Delivery across skin is striking due to its easy convenience. However, drug delivery across skin is still a confront in biomedical sciences. Over the past few decades, various successful narrative devices and techniques have emerged to optimize drug delivery across skin whose barricading behaviour constricts entry of most of the therapeutic agents. Ethosomes are non-invasive delivery transporter that enables drugs to reach the deep skin layers and/or the systemic circulation. Although ethosomal systems are theoretically sophisticated, they are characterized by simplicity in their preparation, efficacy and safety. A combination that can highly inflate their application. Ethosomes are soft, malleable vesicles adapted for enhanced delivery of active agents. This article reviews work carried out method of preparation, application and characterization of ethosomal systems. Because of their exceptional structure, ethosomes are able to encapsulate and deliver through the skin highly lipophilic molecules such as testosterone, cannabinoids and minoxidil as well as cationic drugs such as trihexyphenidil and propranolol. Results obtained in a double-blind two-armed randomized clinical study showed that treatment with the ethosomal acyclovir formulation appreciably improved all the evaluated parameters. In further work, the ethosomal expertise was broadened to introduce agents into cultured cells and microorganisms. Enhanced delivery of bioactive molecules through the skin and cellular membranes by means of an ethosomal transporter opens numerous confronts and prospects for the research and future development of novel improved therapies.
INTRODUCTION
The impending benefits related to transdermal drug delivery are widely reported in the literature 1, 2 . Among these advantages are compact side effects and prevention of first-pass hepatic elimination and intestinal degradation. However, percutaneous delivery of most molecules is often excluded because of the barrier nature of the skin, which functionally impedes the entrance of exogenous materials. To overcome this obstruction, various methods of skin permeation enhancement described in numerous scientific works and patents have been used 3, 4 . Human skin has a multifunctional role including its major role as a barrier against both the outlet of endogenous substances (water) and the entrance of xenobiotic material (chemicals and drugs). It is regarded as first line of protection in human body. The stratum corneum consisting corneocytes mainly accounts for the barrier properties of skin 5, 6 . From some time several aspect have come out which has given immense esteem and rapid progress to transdermal delivery formulations over conventional formulations because circumvention of variations which appear at gastro-intestinal absorption 7 , improvement in bioavailability of drugs by delivering the active principles directly into the systemic circulation, bypassing the hepatic metabolism 8 , by giving a constant, controlled drug enter decreasing the variations in drug plasma levels 9 , augmentation in patient compliance by providing a simplified way of administration, lowest risk of trauma or any other injury of tissue. In order to increase the permeability of the skin for transdermal delivery of drugs several passive as well as active procedure have been proposed such as penetration enhancers, vesicles, iontophoresis, supersaturated systems, electroporation, phonophoresis, use of microneedles and jet injectors, etc. Although all the efforts devoted to penetration enhancement, only few bioactive agents are currently transdermally administered. One of the most utilizable methods for drugs' transport across the skin is the use of vesicle formulation as skin delivery systems. Ethosomes are soft, malleable lipid vesicles composed mainly of phospholipids, alcohol in relatively high concentration (20-45%) and water ( Fig. 1 ). Ethosomes were first developed by Touitou and her colleagues in 1997 [10] [11] [12] . This transporter presents interesting features correlated with its ability to permeate whole through the human skin due to its high deformability. The physicochemical characteristics of ethosomes allow these vesicular phospholipids as the vesicle forming component of ethosomal system. Phospholipids with various chemical structures like phosphatidyl choline, phosphatidyl ethanolamine are used at concentrations ranging from 0.5-10%.
Figure 1: Structure of ethosomes 13

Structure of skin
Stratum corneum is the remotest layer of the epidermis. It consists of 10 to 25 layers of dead, elongated, fully keratinized corneocytes, which are fixed in a matrix of lipid bilayers. It has been exposed that the stratum corneum is the main barrier to penetration through the skin. When a topical formulation is placed on the skin, the active drug is required to penetrate through the stratum corneum into the viable tissue (Fig 2) . The limiting factor for these processes is the slow diffusion through the dead horny layer of skin. Stratum corneum behaves as a hydrophobic membrane. The rates of permeation of skin by low and high molecular weight organic non electrolytes are mostly determined within the stratum corneum 14, 15 . 
COMPOSITION OF ETHOSOMES
Ethosomes exhibit lipid bilayer like liposomes; however they differ from liposomes in terms of composition (high content of ethanol). The ethosomes are composed of hydroalcoholic or hydro/glycolicphospholipid in which the concentration of alcohol is relatively high. Ethosomes may contain phospholipids with various chemical structures like phosphatidylcholine, phosphatidic acid, phosphatidylserine, Phosphatidyl ethanolamine, phosphatidyl glycerol, phosphatidyl inositol, alcohol (ethanol or isopropyl alcohol), water and propylene glycol (or other glycols). Some preferred phospholipids such as Phospholipon 90 (PL-90). It is usually employed in a range of 0.5-10% w/w. Cholesterol at concentrations ranging between 0.1-1% can also be added to the preparation. Alcohol, such ethanol and isopropyl alcohol; among glycols, propylene glycol and Transcutol are generally used which may range from 20 to 50% in the final product. In addition to non-ionic surfactants (PEG-alkyl ethers) and cationic lipids (cocoamide, POE alkyl amines, dodecylamine, cetrimide etc) can be combined with the phospholipids in the preparations 17 . The concentration of the non-aqueous phase (alcohol and glycol combination) may range between 22 to 70%. Various additives which are used for formulation of ethosomes are listed in the 
Disadvantages of ethosomal drug delivery
1. Ethosomes with poor shells may clump together and leads to precipitation. 2. Adequate solubility of the drug in both lipophilic and aqueous environments to reach dermal microcirculation and gain access to the systemic circulation.
3. Skin irritation or dermatitis due to excipients and enhancers of drug delivery systems. 4. Ethosomal administration is not a means to achieve rapid bolus type drug input, rather it usually designed to offer slow, sustained drug delivery. 5. Drugs that require high blood levels cannot be administered -limited to only potent drugs (daily dose -10mg or less) 6. Poor practical yield. 7. Transfer of ethosomes from organic to aqueous layer leads to loss of product 8. The molecular size of the drug should be reasonable that it should be absorbed percutaneously. 9. Adhesive may not adhere well to all types of skin. 10. May not be economical. 11. In case if shell locking is ineffective then the ethosomes may coalescence and fall apart on transfer into water [24] [25] [26] [27] [28] [29] .
MECHANISM OF DRUG PENETRATION
The mechanism of penetration of the ethosomes involves two concurrent mechanisms of ethanol effect and ethosome effect on the stratum corneum lipid bilayer Because of the use of ethanol in the preparation of the ethosomes, the deformability of the vesicles is increased. The high alcohol content is expected to partially extract the stratum corneum lipids (Fig 3) .These processes are responsible for increasing inter and intracellular permeability of ethosomes. The ultra deformable vesicles can move in the path of the disordered stratum corneum and finally release drug in the deeper layers of the skin 30 .
 Ethosomes effect  Ethanol effect
Ethosomes effect
Increased cell membrane lipid fluidity caused by the ethanol of ethosomes results increased skin permeability. So the ethosomes permeates very easily inside the deep skin layers, where it got fused with skin lipids and releases the drugs into deep layer of skin
Ethanol effect
Ethanol acts as a penetration enhancer through the skin. The mechanism of its penetration enhancing effect is well known. Ethanol penetrates into intercellular lipids and increases the fluidity of cell membrane lipids and decrease the density of lipid multilayer of cell membrane 31 . 
METHODS OF PREPARATION
Ethosomes can be prepared and formulated by four methods. All methods are sound simple and convenient because no need of complex processes or sophisticated instruments.
Cold method
This is the most common method utilized for the preparation of ethosomal formulation. In this method phospholipid, drug and other lipid materials are dissolved in ethanol in a covered vessel at room temperature by vigorous stirring with the use of mixer. Propylene glycol or other polyol is added during stirring. This mixture is heated to 300C in a water bath. The water heated to 300C in a separate vessel is added to the mixture, which is then stirred for 5 min in a covered vessel. The vesicle size of ethosomal formulation can be decreased to desire extend using sonication 32 or extrusion 33 method. Finally, the formulation is stored under refrigeration 34 . 
Hot method
In this method phospholipid is dispersed in water by heating in a water bath at 400C until a colloidal solution is obtained. In a separate vessel ethanol and propylene glycol are mixed and heated to 400C. Once both mixtures reach 400C, the organic phase is added to the aqueous one. The drug is dissolved in water or ethanol depending on its hydrophilic/ hydrophobic properties. The vesicle size of ethosomal formulation can be decreased to the desire extent using probe sonication or extrusion method 35 .
Classic method
The phospholipid and drug are dissolved in ethanol and heated to 30°C±1°C in a water bath. Double distilled water is added in a fine stream to the lipid mixture, with constant stirring at 700rpm, in a closed vessel. The resulting vesicle suspension is homogenized by passing through a polycarbonate membrane using a hand extruder for three cycles 36 .
Mechanical dispersion method
Soya phosphotidylcholine is dissolved in a mixture of chloroform: methanol in round bottom flask (RBF). The organic solvents are removed using rotary vacuum evaporator above lipid transition temperature to form a thin lipid film on wall of the RBF. Finally, traces of solvent mixture are removed from the deposited lipid film by leaving the contents under vacuum overnight. Hydration is done with different concentration of hydroethanolic mixture containing drug by rotating the RBF at suitable temperature 36 .
CHARACTERIZATION OF ETHOSOMES 37
Vesicle size and Zeta potential
Particle size and zeta potential can be determined by dynamic light scattering (DLS) using a computerized inspection system and photon correlation spectroscopy (PCS).
Vesicle shape
Visualization of ethosomes can be done using transmission electron microscopy (TEM) and by scanning electron microscopy (SEM). Visualization by electron microscopy reveals a thosomal formulation exhibited vesicular structure 300-400 nm in diameter. The vesicles seem to be alleable as evident by their imperfect round shape.
Entrapment efficiency
The entrapment efficiency of drug in ethosomes can be measured by the ultracentrifugation technique. The chemical nature of the lipid is an important factor in determining the EE of drug in the ethosomes because lipid which forms bilayer structure holds the drug perfectly. On the other hand, the imperfection of the lipid structure could offer space to accommodate the drug. The vesicles are separated in a high speed cooling centrifuge at 20,000 rpm for 90 minutes in the temperature maintained at 4°C. Separate the sediment and supernatant liquids determine the amount of drug in the sediment by lysing the vesicles using methanol.
% Entrapment = Actual content/Theoretical content x 100
Surface tension measurement
The surface tension activity of drug in aqueous solution can be measured by the ring method in a Du Nouy ring tensiometer.
Surface morphology study
Different types of lipids influence the surface morphology or shape of the particles. Lipid microparticle suspensions were deposited on metallic stubs then placed in liquid nitrogen and dried under vacuum. The freeze-dried microparticles were coated uniformly with gold. It is characterized for morphology and surface properties using a scanning electron microscope.
Drug content
Drug content of the ethosomes can be determined using UV spectrophotometer. This can also be quantified by a modified high performance liquid chromatographic method.
Transition temperature
The Transition temperature (T) of vesicular lipids is measured in duplicate by DSC in an aluminum pan at a heating rate of 10°C per min within a temperature range from 20º-300ºC., under a constant nitrogen stream
Stability studies
The ability of ethosomal preparations to retain the drug (i.e., drug-retentive behavior) can be checked by keeping the preparations at different temperatures, i.e., 25 ± 2°C (room temperature, RT), 37 ± 2°C and 45 ± 2°C for different periods of time (1, 20, 40, 60, 80 and 120 days). The ethosomal preparations were kept in sealed vials (10 ml capacity) after flushing with nitrogen. The stability of ethosomes was also determined quantitatively by monitoring size and morphology of the vesicles using DLS and TEM.
Degree of deformability and turbidity
The degree of deformability of the Ethosomal preparation can be performed by extrusion method and the turbidity of the preparation can be performed by using nephelometer 
Skin permeation studies
Confocal laser scanning microscopy (CLSM) method is used to determine the depth of penetration from Ethosomes. The ethosomes shows significantly higher skin deposition possibly due to combined effect of ethanol and phospholipid thus providing a mode for dermal and transdermal delivery.
In vitro drug release study and Drug deposition study
In vitro drug release study and drug deposition of ethosomal preparation can be performed by Franz diffusion cell with artificial or biological membrane, Dialysis bag diffusion.
Phospholipid-ethanol interaction
The Phospholipid-ethanol interaction was studied by using Proton decoupled 31P-NMR and Differential Scanning calorimetry.
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Vesicle-skin interaction study by TEM and SEM
From animals ultra-thin sections were cut (Ultracut, Vienna, Austria), collected on formvar coated grids and examined under transmission electron microscope. For SEM analysis, the sections of skin after dehydration were mounted on stubs using an adhesive tape and were coated with gold palladium alloy using a fine coat ion sputter coater. The sections were examined under scanning electron microscope.
Filter membrane-vesicle interaction study by scanning electron microscopy
Vesicle suspension (0.2 mL) was applied to filter membrane having a pore size of 50 nm and placed in diffusion cells. The upper side of the filter was exposed to the air, whereas the lower side was in contact with PBS (phosphate buffer saline solution), (pH 6.5). The filters were removed after 1 hour and prepared for SEM studies by fixation at 4°C in Karnovsky's fixative overnight followed by dehydration with graded ethanol solutions (30%, 50%, 70%, 90%, 95%, and 100% vol/vol in water). Finally, filters were coated with gold and examined in SEM.
Vesicle-skin interaction study by fluorescence microscopy
Fluorescence microscopy was carried according to the protocol used for TEM and SEM study. Paraffin blocks are used, were made, 5-μm thick sections were cut using microtome (Erma optical works, Tokyo, Japan) and examined under a fluorescence micro Cytotoxicity Assay MT-2 cells (Tlymphoid cell lines) were propagated in Dulbecco's modified Eagle medium (HIMEDIA, Mumbai, India) containing 10% fetal calf serum, 100 U/mL penicillin, 100 mg/mL streptomycin, and 2 mmol/L Lglutamine at 37°C under a 5% CO2 atmosphere. Cytotoxicity was expressed as the cytotoxic dose 50 (CD50) that induced a 50% reduction of absorbance at 540nm.
Skin permeation studies
The hair of test animals (rats) were carefully trimmed short (<2 mm) with a pair of scissors, and the abdominal skin was separated from the underlying connective tissue with a scalpel. The excised skin was placed on aluminums foil, and the dermal side of the skin was gently teased off for any adhering fat and/or subcutaneous tissue. The effective permeation area of the diffusion cell and receptor cell volume was 1.0 cm2 and 10 mL, respectively. The temperature was maintained at 32°C ± 1°C. The receptor compartment contained phosphate buffer saline solution (10 mL of pH 6.5). Excised skin was mounted between the donor and the receptor compartment. Ethosomal formulation (1.0 mL) was applied to the epidermal surface of skin. Samples (0.5 mL) were withdrawn through the sampling port of the diffusion cell at 1, 2, 4, 8, 12, 16, 20 & 24 hour time intervals and analyzed by high performance liquid chromatography assay.
HPLC Assay
The amount of drug permeated in the receptor compartment during in vitro skin permeation experiments and in MT-2 cell was determined by HPLC assay.
Drug uptake studies
The uptake of drug into MT-2 cells (1×106 cells/mL) was performed in 24-well plates (Corning Inc) in which 100 μL RPMI medium was added. Cells were incubated with 100 μL of the drug solution in phosphate buffer saline solution (pH 7.4), ethosomal formulation, or marketed formulation, and then drug uptake was determined by analyzing the drug content by HPLC assay.
Statistical analysis
Statistical significance of all the data generated was tested by employing ANOVA followed by studentized range test. A confidence limit of P < .05 was fixed for interpretation of the results using the software PRISM (GraphPad, Version 2.01, San Diego, CA).
APPLICATION OF ETHOSOMES
Ethosomes find its diverse applications in various categories of drugs like Antifungal, Antibiotics, Skin infections and Cosmetic field. Some are listed as below (Table 2) . Marketed product of ethosomes 41, 42 In 2000, the ethosomes technology began to Commercialize. There are many companies which developed ethosomes products (Table 3) . Novel Therapeutic Technologies Inc (NTT) of Hebrew University has been succeeded in bringing a number of products to the market based on ethosome delivery system Table 4 . 
CONCLUSION
Ethosomes are a pioneering platform technology that offers modified delivery systems to meet the necessary criteria for efficient and safe drug administration into and across the skin. Considerable research has been conducted to characterize this novel non-invasive carrier. Because of their composition, ethosomes are soft vesicles, which penetrate through the SC lipids and transport the active agent to the deep layers of the skin. These vesicular systems were proven efficient for dermal and transdermal delivery of various energetic agents in animals and humans. Among the many areas where ethosomal transdermal delivery could be helpful are Parkinson's disease, hormone replacement therapy, cardiovascular treatments and rheumatic disorders. Delivery of antibiotics and antiviral to the deep layers of the skin and drugs for management of alopecia to the hair follicles by an ethosomal carrier could greatly increase drug treatment competence and patient convenience. The highly competent delivery, together with its lack of toxicity and preparation simplicity, makes this system a promising candidate for the administration of chemical and biological compounds. Such developments may further increase the field of transdermal applications.
